CCEP CCEP NDX
Company Profile ↓Company Overview
CCEP (CCEP) is a publicly traded company listed on with a market capitalization of $47.50B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 24.8%, reflecting efficient use of shareholder capital.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $20.90B (+2.3% YoY); net profit $1.94B.
- Trailing 12 Months Year-on-year growth — revenue +2.3%, earnings +37.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.5%, profit CAGR 8.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.46% |
| 1 Year: | 2.27% |
Compounded Profit Growth
| 5 Years: | 8.80% |
| 1 Year: | 36.95% |
Stock Price Performance
| 1 Year: | +22.17% |
| 6 Months: | +6.66% |
| 3 Months: | +11.63% |
| 1 Month: | -2.30% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)44.87 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 24.8%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 17.32B | 18.30B | 20.44B | 20.90B |
| Cost of Revenue | 11.10B | 11.58B | 13.23B | 13.46B |
| Gross Profit | 6.22B | 6.72B | 7.21B | 7.44B |
| Operating Expenses | 3.99B | 4.39B | 4.68B | 4.65B |
| Operating Income | 2.23B | 2.33B | 2.54B | 2.79B |
| EBITDA | 2.94B | 3.16B | 3.11B | 3.77B |
| Interest Expense | 162.00M | 162.00M | 242.00M | 274.00M |
| Pretax Income | 1.96B | 2.20B | 1.94B | 2.57B |
| Tax Provision | 436.00M | 534.00M | 492.00M | 590.00M |
| Net Income | 1.51B | 1.67B | 1.42B | 1.94B |
| Diluted EPS | 3.29 | 3.63 | 3.08 | 4.26 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 29.31B | 29.25B | 31.10B | 29.87B |
| Current Assets | - | 6.54B | 6.61B | 6.64B | 6.08B |
| Cash & Equivalents | - | 1.39B | 1.42B | 1.56B | 918.00M |
| Inventory | - | 1.38B | 1.36B | 1.61B | 1.55B |
| Receivables | - | 2.47B | 2.55B | 2.56B | 2.69B |
| Total Liabilities | - | 21.87B | 21.28B | 22.11B | 21.57B |
| Current Liabilities | - | 7.31B | 7.28B | 8.15B | 7.58B |
| Long Term Debt | - | 10.04B | 9.55B | 9.39B | 9.69B |
| Total Debt | - | 11.91B | 11.40B | 11.33B | 10.69B |
| Total Equity | - | 7.45B | 7.98B | 8.49B | 7.83B |
| Shares Outstanding | - | 457.11M | 459.20M | 460.95M | 449.09M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.93B | 2.81B | 3.06B | 2.95B |
| Investing Cash Flow | - | -645.00M | -937.00M | -1.96B | -632.00M |
| Financing Cash Flow | - | -2.28B | -1.82B | -973.00M | -2.89B |
| Capital Expenditure | - | -603.00M | -812.00M | -939.00M | -950.00M |
| Free Cash Flow | - | 2.33B | 1.99B | 2.12B | 2.00B |
| Net Change in Cash | - | 11.00M | 47.00M | 131.00M | -569.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 35.9% | 36.7% | 35.3% | 35.6% |
| Operating Margin % | 12.9% | 12.7% | 12.4% | 13.4% |
| Net Margin % | 8.7% | 9.1% | 6.9% | 9.3% |
| ROE % | 20.2% | 20.9% | 16.7% | 24.8% |
| ROCE % | 10.2% | 10.6% | 11.0% | 12.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CCEP
CCEP slips as a fresh Wall Street downgrade adds to valuation concerns - quiverquant.com
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNRTlKWVBIMGpMdHdrVjFlUUFZdW0yazhQeGg2Z29VV3NReWp4SlIyTXdfd3QzS2JqYXpaa3JQT0JWTXRuOHVSR2N6UGlYZjl0UlV1VzZBTXVNdnUzelJhdXNNZUJzclhuamJhR2JobWxMYXNwYlhGNzBTU19QLW5aUFR0SS1Dd0tZZ2E3V1…
Coca-Cola Europacific Partners $CCEP Shares Purchased by NEOS Investment Management LLC - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcGF4V2k0Yi1iWW01SW45eWh2SGsta2NYS1dSX1pNSFRhVmhNOGdMa2Z0QksyQnZMRzRBT1lheE9VR3QxOUJ0VC1ZMkhNbEtzbE14T0owUTlYZ2tUbFNRVTB4RFFERTBZY2ppeEF3dVJzN0c1LTIwdmVObEZNUjJtQVIyb09VU1BWSXRuUG…
FMX vs. CCEP: Which Stock Is the Better Value Option? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNTTM3akVqVWNvLThhSjNYMVhPNVpsRjIxTWZRdFUwMUtwdldtcl9lMFNtN09jb3hMUC1TSXhpcFpoc2FRazNDRW4yZm5rYlNkQ2F1aVIyLXVfcllfZkVPSEE1VEpkY25WUXhyM25QcUpyN19hZDJaR3RqVi13Qm5IV3k0QkdWUjdVbmJVLU…
A Look at Coca-Cola Europacific Partners PLC (CCEP) After 3.1% D - GuruFocus
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQNUZ5SkV0X2FCQ194NGlXV25QbjdmRXhDQlBCRHVBeXR4cmhRN3JtNk5wQ0ZDRGxrWVp1UVl2TFctUk91dmhVWkhXczYzeGxUZVFRZm9FMEdOck9tWjFNQmN4SnhHNGw0SUwzeU1sSGUzM3RXaWMxTml2QklveldWSi1WNW1hV0ppNnlLcT…
Executive share awards and new shares at Coca-Cola Europacific Partners (CCEP) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNTjJXXzlEZHBjQkJYLTJHb2RjWFpSMkJwMEdhaUFIYm5VLTV6Nzc0T1NwNHhvSHZtVW90czhTakRacVh3YVgxQkhFeG00R0hud0tmVmo5ZzF5aGxDS2sxeVEtS1pXZDhQYVRyUFEzSGl5QjQ1ODFIdHJaS3liREZFRV8yemRhMWZzek1rY0…
CCEP Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5tYjB6QmUwQlI4OTFhai1OUWhiVnVnQXR1UWpNd2pVa292T09FQmJzeEI3dFkzeHJ5ajBGZTBUR2pXdGVUcVlQMDRXa005QlZKbG1ycUgtRW5CNjBEMmRNSFhIZlV2MUMwYUFmZ3hlVGJmUFR2MV9xMWNB?oc=5" target="_blank">CCE…
CCEP — Frequently Asked Questions
What is the current share price of CCEP?
As of 2026-09-07 16:24 PDT, CCEP trades at $105.76 on NASDAQ/NYSE. Its 52-week range is $83.96 to $111.71.
What is the market capitalisation of CCEP?
CCEP has a market capitalisation of $47.50B on NASDAQ/NYSE.
What is the P/E ratio of CCEP?
CCEP trades at a trailing price-to-earnings (P/E) ratio of 24.83. Its price-to-book (P/B) ratio is 6.06.
What is the return on equity (ROE) of CCEP?
CCEP has a return on equity (ROE) of 24.79%. Its return on capital employed (ROCE) is 12.53%.
Is CCEP a good stock to buy?
This page provides a data-driven analysis of CCEP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.